Bruker Q4 EPS of $0.59 Misses Forecast, Organic Revenue Falls 5%
Bruker reported Q4 adjusted EPS of $0.59, missing analyst forecasts by $0.07 and down 22.4% year-on-year, while Q4 revenue was $977.2 million, flat overall but down 5% on an organic basis. 2026 adjusted EPS guidance slightly trails Wall Street estimates even as full-year revenue forecast surpasses expectations.
1. Fourth Quarter Results
Bruker posted adjusted EPS of $0.59 in Q4 2025 versus consensus of $0.66, marking a 22.4% decline from the prior year. Total revenue reached $977.2 million, matching last year’s level but showing a 5% drop on an organic basis.
2. Year-Over-Year Trends
The EPS miss reflects continued margin pressure, with adjusted earnings per share tumbling from $0.76 in Q4 2024. While headline revenue held steady, underlying sales weakened in key end markets, driving the organic revenue contraction.
3. 2026 Guidance Outlook
Management set 2026 adjusted EPS guidance slightly below analysts’ estimates, signaling cautious profitability assumptions. At the same time, full-year revenue is forecast to grow modestly above consensus, hinting at a potential recovery in top-line performance.
4. Stock Reaction
Shares plunged over 10% in early trading following the earnings release, reflecting investor concern over the profit shortfall. The stock is now more than 30% below its 52-week high as the market digests weaker margins and tempered earnings visibility.